PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-May-2026 Ibex Medical Analytics Establishes Biopharma Advisory Board to Advance AI-Powered Precision Diagnostics Businesswire
05-May-2026 Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response, Enabling Precision Medicine in Obesity and MASH Businesswire
05-May-2026 SonoThera to Present Non-Viral RIPPLE™ Platform Data Demonstrating Multi-Tissue Delivery and Gene Expression at ASGCT 2026 Businesswire
05-May-2026 Aegis Software Named a Representative Vendor in Gartner® Market Guide for Manufacturing Execution Systems Businesswire
05-May-2026 GC Therapeutics Appoints Stem Cell Therapy Leader Stefan Irion, MD, as Chief Scientific Officer Businesswire
05-May-2026 Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model Businesswire
05-May-2026 Bracco Launches BubbleGen™ Early Access Program for Microbubble-Based Cell Selection and Activation at ISCT Businesswire
05-May-2026 New Pharmaceutical Reform Alliance Poll: Americans Agree on One Thing – Rein in Big Pharma Businesswire
05-May-2026 Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership Businesswire
05-May-2026 Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals Businesswire
05-May-2026 Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 Businesswire
05-May-2026 BlinkRx Announces Availability of RYALTRIS® for Convenient Home Delivery Following Glenmark’s Commercial Transition Businesswire
05-May-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
05-May-2026 Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer Businesswire
05-May-2026 ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting Businesswire
05-May-2026 Rob Ramirez Joins Inlightened as Head of Strategy Businesswire
05-May-2026 Neuraly, Inc. Supports Phase 2 Investigator-Initiated Trial of Pegsebrenatide (NLY01) for Progressive Multiple Sclerosis Businesswire
05-May-2026 Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update Businesswire
05-May-2026 Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress Businesswire
05-May-2026 AdaptHealth Corp. Announces First Quarter 2026 Results Businesswire